Comparison of once- or twice-daily bimatoprost with twice-daily timolol in patients with elevated IOP
Authors:
- James D BrandtJBJames D Brandt
- Amanda M VanDenburghAVAmanda M VanDenburgh
- Kuankuan ChenKCKuankuan Chen
- Scott M WhitcupSWScott M Whitcup
- 1 June 2001
- journal article
- clinical trial
- Published by Elsevier in Ophthalmology
- Vol. 108 (6) , 1023-1031
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Effects of AGN 192024, a new ocular hypotensive agent, on aqueous dynamicsAmerican Journal of Ophthalmology, 2001
- Replacement of the carboxylic acid group of prostaglandin F2α with a hydroxyl or methoxy substituent provides biologically unique compoundsBritish Journal of Pharmacology, 2000
- Effects of systemic β-blocker therapy on the efficacy and safety of topical brimonidine and timolol11None of the clinical investigators or authors have a proprietary interest in the products discussed in this manuscript; Pamela Barnett, Amy Batoosingh, Kuankuan Chen, Robert David, MD, Marsha Harrold, and Amanda VanDenburgh are employees of Allergan, Inc.Ophthalmology, 2000
- Antiglaucoma medications: A review of safety and tolerability issues related to their useClinical Therapeutics, 2000
- Systemic side effects of topical beta‐adrenergic blockersClinical Cardiology, 1996
- Comparison of Latanoprost and Timolol in Patients with Ocular Hypertension and GlaucomaOphthalmology, 1996
- A Long-term Clinical Trial of Timolol Therapy Versus No Treatment in the Management of Glaucoma SuspectsOphthalmology, 1989
- Shortterm “escape” and longterm “drift.”. The dissipation effects of the beta adrenergic blocking agentsSurvey of Ophthalmology, 1983
- Why Do Some People Go Blind from Glaucoma?Ophthalmology, 1982
- Rank Transformations as a Bridge Between Parametric and Nonparametric StatisticsThe American Statistician, 1981